Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary
embolism. VTE is the leading cause of lost disability-adjusted life years and the third …

Blood-contacting medical devices are an integral part of modern medicine. Such devices may
be used for only a few hours or may be implanted for life. Despite advances in biomaterial …

Catheter associated thrombosis is an ongoing problem. Omniphobic coatings based on
tethering biocompatible liquid lubricants on self-assembled monolayers of hydrophobic …

Background Patients with mechanical heart valves ( MHV ) require warfarin to prevent
thromboembolism. Although dabigatran was as effective as warfarin for stroke prevention in atrial …

Aims The aim of this review was to assess the effect of concomitant surgical atrial fibrillation (AF)
ablation on postoperative freedom from AF and patient-important outcomes. Methods …

The direct oral anticoagulants (DOACs) have now supplanted vitamin K antagonists (VKAs)
for the treatment of venous thromboembolism (VTE). The DOACs include dabigatran, which …

Background Central venous catheters are prone to clotting, particularly in patients with cancer.
Although low-molecular-weight heparin and direct oral anticoagulants, such as apixaban …

Objectives The authors aimed to identify risk factors and outcomes associated with new-onset
atrial fibrillation (NOAF) after transcatheter aortic valve replacement (TAVR). Background …

Background. Voice recognition software (VRS), with specialized medical vocabulary, is being
promoted to enhance physician efficiency, decrease costs, and improve patient safety. This …

Managing severe valvular heart disease with mechanical valve replacement necessitates
lifelong anticoagulation with a vitamin K antagonist. Optimal anticoagulation intensity for …